Vanilloid receptor ligands and their use in treatments

Details for Australian Patent Application No. 2002364549 (hide)

Owner Amgen, Inc

Inventors Chen, Ning; Fotsch, Christopher H; Zhu, Jiawang; Han, Nianhe; Bo, Yunxin Y; Wang, Xianghong; Kelly, Michael G; Doherty, Elizabeth M; Chakrabarti, Partha P; Norman, Mark Henry; Liu, Qingyian

Agent Shelston IP

Pub. Number AU-B-2002364549

PCT Number PCT/US02/39589

PCT Pub. Number WO2003/049702

Priority 60/383,331 22.05.02 US; 60/402,422 08.08.02 US; 60/339,161 10.12.01 US; 60/344,737 21.12.01 US

Filing date 10 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 22 November 2007

International Classifications

C07D 249/18 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/36 (2006.01)

A61K 31/37 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/404 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4184 (2006.01)

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/443 (2006.01)

A61K 31/444 (2006.01)

A61K 31/453 (2006.01)

A61K 31/47 - Quinolines

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/383,331 22.05.02 US; 60/402,422 08.08.02 US; 60/339,161 10.12.01 US; 60/344,737 21.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002364549

21 October 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Amgem, Inc. to Amgen, Inc 2003

22 November 2007 Application Accepted

  Published as AU-B-2002364549

20 March 2008 Standard Patent Sealed

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364550-METHODS AND APPARATUS FOR LEUKOREDUCTION OF RED BLOOD CELLS

2002364548-METHOD AND APPARATUS FOR SELECTING RATING LIMITS IN A PARENTAL CONTROL SYSTEM